Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.
AuthorsGoodger, Sarah J
Robinson, Christopher J
Murphy, Kevin J
Harmer, Nicholas J
Blundell, Tom L
Pye, David A
Gallagher, John T
AffiliationPaterson Institute for Cancer Research, University of Manchester, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractHeparin-like saccharides play an essential role in binding to both fibroblast growth factors (FGF) and their receptors at the cell surface. In this study we prepared a series of heparin oligosaccharides according to their size and sulfation level. We then investigated their affinity for FGF2 and their ability to support FGF2 mitogenesis of heparan sulfate-deficient cells expressing FGFR1c. Tetra- and hexasaccharides bound FGF2, but failed to dimerize the growth factor. Nevertheless, these saccharides promoted FGF2-mediated cell growth. Furthermore, whereas enzymatic removal of the non-reducing end 2-O-sulfate group had little effect on the 1:1 interaction with FGF2, it eliminated the mitogenic activity of these saccharides. This evidence supports the symmetric two-end model of ternary complex formation. In contrast, even at very low concentrations, octasaccharide and larger heparin fragments conferred a potent mitogenic activity that was independent of terminal 2-O-sulfation. This correlated with the ability to dimerize FGF2 in an apparently cooperative manner. This data suggests that potent mitogenic signaling results from heparin-mediated trans-dimerization of FGF2, consistent with the asymmetric model of ternary complex formation. We propose that, depending on saccharide structure, there are different architectures and modes of ternary complex assembly that differ in stability and/or efficiency of transmembrane signaling.
CitationEvidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. 2008, 283 (19):13001-8 J. Biol. Chem.
JournalThe Journal of Biological Chemistry
- In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
- Authors: Guillonneau X, Tassin J, Berrou E, Bryckaert M, Courtois Y, Mascarelli F
- Issue date: 1996 Jan
- Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
- Authors: Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC
- Issue date: 1993 Nov 15
- Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.
- Authors: Jastrebova N, Vanwildemeersch M, Rapraeger AC, Giménez-Gallego G, Lindahl U, Spillmann D
- Issue date: 2006 Sep 15
- Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
- Authors: Safran M, Eisenstein M, Aviezer D, Yayon A
- Issue date: 2000 Jan 1
- Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.
- Authors: Robinson CJ, Harmer NJ, Goodger SJ, Blundell TL, Gallagher JT
- Issue date: 2005 Dec 23